Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01347619 · ClinicalTrials.gov registry record · NA
iADAPT: Off Label Use of Antipsychotics in the Nursing Home
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT01347619 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 42 participants.
The verdict
NCT01347619, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The investigators propose to evaluate the effectiveness of 3 different methods to promote the dissemination and adoption of evidenced-based review guides into the nursing home setting. Specifically, the investigators will adapt Comparative Effectiveness Research (CER) Review products developed by the Agency for Healthcare Research and Quality (AHRQ), specifically related to off-label use of atypical antipsychotic drugs, to improve their penetration into practice in the nursing home (NH) setting. The investigators propose the following specific aims: AIM 1: NEEDS ASSESSMENT To conduct a needs assessment for the NH setting relevant to the AHRQ Comparative Effectiveness Research Summary Guide (CERSG) entitled "Off-Label Use of Atypical Antipsychotic Drugs." The assessment will identify: (a) interest in and barriers to the use of the AHRQ atypical antipsychotic CERSG in the NH setting; (b) the key audiences and stakeholders that influence atypical antipsychotic drug use in NHs; and (c) approaches to integrating comparative effectiveness research products into the NH setting. AIM 2: PRODUCTION OF THE TOOLKIT Guided by the needs assessment, the investigators will produce a toolkit containing tailored CERSG-based products targeting key audiences and stakeholders in the NH setting. The target audience(s) of the final CERSG-based products will be identified in Aim 1, and will potentially include: (a) facility leadership \[NH administrator, Medical Director, Director of Nursing\]; (b) prescribers and consultant pharmacists; (c) nursing staff \[registered nurses, licensed practical nurses, and certified nurse assistants\]. AIM 3: EVALUATING THE EFFECTIVENESS OF THE TOOLKIT To evaluate the effectiveness of the toolkit and three dissemination strategies using a matched, cluster randomized trial. NHs in the first arm will receive the toolkit only and web access to the materials; NHs in the second arm will receive the toolkit, web access, periodic audit and feedback reports of
Interventions
- OTHER Toolkit only with Web Access to Online Version
- OTHER Toolkit, Periodic Audit/Feedback, Educational Messages
- OTHER Items in Arm 2 plus Academic Detailing Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01347619
The ClinicalTrials.gov registry entry for NCT01347619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Toolkit only with Web Access to Online Version is the first listed.
NCT01347619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01347619 about?
NCT01347619 is a clinical study titled "iADAPT: Off Label Use of Antipsychotics in the Nursing Home". The investigators propose to evaluate the effectiveness of 3 different methods to promote the dissemination and adoption of evidenced-based review guides into the nursing home setting. Specifically, the investigators will adapt Comparative Effectiveness Research (CER) Review products developed by th...
What is the current status of trial NCT01347619?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2010-11. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01347619?
The interventions under investigation include: Toolkit only with Web Access to Online Version (OTHER), Toolkit, Periodic Audit/Feedback, Educational Messages (OTHER), Items in Arm 2 plus Academic Detailing Program (OTHER).
Who is sponsoring clinical trial NCT01347619?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.